2-Propen-1-one, 1-(3-fluoro-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)- manufacturers
- JC2-11
-
- $38.00
-
2026-07-27
- CAS:937820-89-8
- Purity: 99.88%
- Supply Ability: 10g
|
| | 2-Propen-1-one, 1-(3-fluoro-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)- Basic information |
| | 2-Propen-1-one, 1-(3-fluoro-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)- Chemical Properties |
| Boiling point | 482.0±45.0 °C(Predicted) | | density | 1.257±0.06 g/cm3(Predicted) | | solubility | DMSO: Sparingly soluble: 1-10 mg/ml | | form | Solid | | pka | 9.67±0.31(Predicted) | | color | Off-white to yellow |
| | 2-Propen-1-one, 1-(3-fluoro-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)- Usage And Synthesis |
| Uses | JC2-11 is an inhibitor of inflammatory corpuscles. JC2-11 inhibits domain-containing protein NLRC 4, absent in melanoma 2 (AIM 2) and non-canonical (NC) inflammatory corpuscles. JC2-11 reduces the secretion of caspase-1 (p20), the cleavage of gasdermin D (GSDMD), and the releases of IL-1β and lactate dehydrogenases (LDH) in inflammatory bodies. JC2-11 inhibits the activation of inflammatory bodies by destroying the production of reactive oxygen species and the activity of caspase-1[1]. | | in vivo | JC2-11 (250 μg/mouse; i.p.; single dose) significantly inhibits the release of caspase-1 (p20) and IL-1β in non-canonical (NC) inflammatory bodies, and weakens the activation of NC inflammatory bodies of C57BL/6 mice model[1]. | Animal Model: | C57BL/6 mice (8 weeks, female)[1]. | | Dosage: | 250 μg/mouse. | | Administration: | Intraperitoneal injection; single dose. | | Result: | Exhibited inhibitory effect on NC inflammatory body. |
| | IC 50 | NLRP3 inflammasome | | References | [1] Lee G, et al, JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation. Sci Rep. 2022 Dec 28;12(1):22484. DOI:10.1038/s41598-022-27129-3 [2] SOYONG JANG Seikwan O Jae Chul Jung. Synthesis of 1,3-diphenyl-2-propen-1-one derivatives and evaluation of their biological activities[J]. Bioorganic & Medicinal Chemistry, 2007, 15 12: Pages 4098-4105. DOI: 10.1016/j.bmc.2007.03.077 |
| | 2-Propen-1-one, 1-(3-fluoro-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)- Preparation Products And Raw materials |
|